bullish

Eubiologics

EuBiologics (206650 KS): Secular Sectoral Tailwind Is Not The Only Catalyst

273 Views15 Apr 2024 19:13
​Eubiologics secures UNICEF order for oral cholera vaccine and expects record-high sales in 2024. The company has plans for production capacity expansion and entry into premium vaccine market.
What is covered in the Full Insight:
  • Eubiologics vaccine order details
  • Impact of global warming
  • Current cholera outbreaks situation
  • Production & Sales Strategy of Eubiologics
  • Eubiologics' potential premium vaccine market entry
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
x